Live news related to AB SCIENCE stock (FR0010557264): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
AB Science revealed preliminary results from Phase 1 of its treatment combining AB8939 and venetoclax for refractory or relapsed acute myeloid leukemi…
AB Science has announced the raising of a gross amount of 2.8 million euros in a private placement aimed at funding its clinical programs, particularl…
AB Science has released its financial results for the first half of 2025, revealing a 24% reduction in its operational deficit, but a 15.8% increase i…
